# Study to Compare Different Formulations of AZD3355

> **NCT00688402** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** AZD3355

## Key facts

- **NCT ID:** NCT00688402
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688402, "Study to Compare Different Formulations of AZD3355". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00688402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*